Azenta Management
Management criteria checks 0/4
Azenta's CEO is John P. Marotta, appointed in Sep 2024, has a tenure of less than a year. total yearly compensation is $1.17M, comprised of 3% salary and 97% bonuses, including company stock and options. directly owns 0.031% of the company’s shares, worth R$4.44M. The average tenure of the management team and the board of directors is 1.9 years and 0.9 years respectively.
Key information
John P. Marotta
Chief executive officer
US$1.2m
Total compensation
| CEO salary percentage | 3.0% |
| CEO tenure | less than a year |
| CEO ownership | 0.03% |
| Management average tenure | 1.9yrs |
| Board average tenure | less than a year |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | US$1m | US$35k | -US$164m |
Compensation vs Market: John P.'s total compensation ($USD1.17M) is above average for companies of similar size in the BR market ($USD682.64K).
Compensation vs Earnings: Insufficient data to compare John P.'s compensation with company performance.
CEO
John P. Marotta (44 yo)
less than a year
Tenure
US$1,170,636
Compensation
Mr. John P. Marotta is President, CEO & Director of Azenta, Inc. from September 9, 2024. Mr. Marotta serves as Executive in Residence at Patient Square Capital, LP since joining the firm in March 16, 2023....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | US$1.17m | 0.031% R$ 4.4m | |
| Senior VP | 13.8yrs | US$2.41m | 0.18% R$ 26.3m | |
| Senior VP and GM of the Genewiz Multiomics & Synthesis Solutions | 5.6yrs | US$1.57m | 0.021% R$ 3.1m | |
| Senior VP & GM of Sample Management Solutions | 1.9yrs | US$1.57m | 0.013% R$ 1.9m | |
| Executive VP & CFO | less than a year | no data | 0.014% R$ 2.1m | |
| VP & Chief Accounting Officer | 1.3yrs | no data | 0.00064% R$ 92.6k | |
| VP and Chief Information & Digital Officer | 7.4yrs | no data | no data | |
| Vice President of Financial Planning & Analysis and Investor Relations | no data | no data | no data | |
| Senior Vice President of Corporate Development | 14.6yrs | no data | no data | |
| Senior VP & Chief HR Officer | 1.3yrs | no data | 0.0011% R$ 165.0k | |
| Senior Vice President of Global Quality & Regulatory | 15.1yrs | no data | no data | |
| VP & CEO of B Medical Systems | 1.2yrs | no data | no data |
1.9yrs
Average Tenure
50.5yo
Average Age
Experienced Management: A2ZT34's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | US$1.17m | 0.031% R$ 4.4m | |
| Independent Director | 1.9yrs | US$262.52k | 0.013% R$ 1.9m | |
| Independent Director | 6.3yrs | US$267.52k | 0.029% R$ 4.1m | |
| Independent Director | less than a year | US$211.27k | 0.016% R$ 2.4m | |
| Independent Director | less than a year | US$221.27k | 0.0076% R$ 1.1m | |
| Independent Director | less than a year | no data | 0.0022% R$ 315.6k | |
| Independent Director | less than a year | US$211.27k | 0.0054% R$ 783.1k | |
| Independent Vice Chair of the Board | 11.5yrs | US$277.52k | 0.065% R$ 9.4m | |
| Independent Director | less than a year | no data | 0.032% R$ 4.7m | |
| Independent Director | 4.7yrs | US$275.02k | 0.028% R$ 4.1m | |
| Independent Chairman | 3.1yrs | US$370.05k | 0.021% R$ 3.0m | |
| Independent Director | less than a year | no data | 0.0022% R$ 315.6k |
0.9yrs
Average Tenure
64yo
Average Age
Experienced Board: A2ZT34's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/28 19:29 |
| End of Day Share Price | 2024/12/12 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Azenta, Inc. is covered by 18 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Christopher Muse | Barclays |
| Brett Hodess | BofA Global Research |
| Yuan Zhi | B. Riley Securities, Inc. |